Niagen Bioscience, Inc. (NAGE)

NASDAQ

$2.10

$-0.42

(-16.67%)

After-Hours

Niagen Bioscience, Inc. (NAGE) Live Price Chart

Last updated: ⁦2026-11-06 00:30:00⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Niagen Bioscience, Inc. (NAGE) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at $2.10, with a market capitalization of $186.74M and a P/E ratio of 11.68. Over the past 52 weeks, its price has ranged from $2.06 to $7.95. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$186.74M
Open	$2.32
Day's High	$14.69
Day's Low	$2.06
Previous Close	$2.52
Volume	1.26M
Average Volume	495.00K
P/E Ratio	11.68
52-Week High	$7.95
52-Week Low	$2.06
Dividend Yield	--
Earnings Date	--

Niagen Bioscience, Inc. (NAGE) After-Hours Stock Price

Niagen Bioscience, Inc. (NAGE) is trading at $2.09 in after-hours trading as of 2026-11-05 23:42:00, down 17.10% ($0.43) from the regular-session close of $2.52.

After-hours trading shows how investors are pricing NAGE after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.

Niagen Bioscience, Inc. (NAGE) 7-Day Stock Price Change

Over the past seven days, Niagen Bioscience, Inc. (NAGE) moved from $2.50 to $2.10, representing a decline of 15.88% ($0.40).

The stock traded between $2.06 and $2.59 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 499.10 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

NAGE 52-Week Price Position

Position in Range: 0.8%

52W Low$2.06

52W High$7.95

NAGE is currently trading at $2.10, placing it 0.8% of the way from its 52-week low of $2.06 to its 52-week high of $7.95. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Niagen Bioscience, Inc. (NAGE)?

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Niagen Bioscience, Inc. Information

Industry	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Employees	117
Exchange	NASDAQ
Company Website	https://www.niagenbioscience.com

How to Buy Niagen Bioscience, Inc. (NAGE) Stock on MEXC

Eligible investors can buy real shares of Niagen Bioscience, Inc. (NAGE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NAGE and Place Your Order

Open the RealStocks trading page and search for NAGE. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Niagen Bioscience, Inc. (NAGE) stock price today?

Niagen Bioscience, Inc. (NAGE) is currently trading at $ 2.10, down 16.55% ($0.42) from the previous close of $ 2.52. Intraday prices update in real time during regular trading hours.

2.Is NAGE stock going up or down today?

As of 2026-11-05 23:42:00, NAGE is trading at $ 2.10, down 16.55% ($0.42) from its previous close of $ 2.52. The stock has traded between $ 2.06 and $ 14.69 during today’s regular session. Past price movements do not guarantee future results.

3.What is NAGE pre-market price?

As of 2026-11-05 23:42:00, NAGE is trading at $ 2.30 in pre-market trading, down 8.93% ($0.23) from the previous close of $ 2.52. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NAGE after-hours price?

As of 2026-11-05 23:42:00, NAGE is trading at $ 2.09 in after-hours trading, down 17.10% ($0.43) from the regular-session close of $ 2.52. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is NAGE stock trading now?

NAGE trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NAGE sit relative to its 52-week high and low?

Over the past 52 weeks, NAGE has traded between a low of $ 2.06 and a high of $ 7.95. At $ 2.10, the stock is positioned 0.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Niagen Bioscience, Inc. in?

Niagen Bioscience, Inc. (NAGE) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Niagen Bioscience, Inc.'s market capitalization and where is it listed?

Niagen Bioscience, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 186.74M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NAGE valued in terms of P/E ratio and EPS?

NAGE trades at a P/E ratio of 11.68, based on trailing-twelve-month EPS of $ 0.20. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Niagen Bioscience, Inc. pay a dividend?

Niagen Bioscience, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.